United Therapeutics Corp. (UTHR)
515.46
-12.45
(-2.36%)
USD |
NASDAQ |
Aug 28, 16:00
515.31
-0.15
(-0.03%)
Pre-Market: 20:00
United Therapeutics Free Cash Flow : 1.084B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.084B |
| March 31, 2026 | 1.011B |
| December 31, 2025 | 1.035B |
| September 30, 2025 | 1.116B |
| June 30, 2025 | 1.068B |
| March 31, 2025 | 1.126B |
| December 31, 2024 | 1.078B |
| September 30, 2024 | 898.10M |
| June 30, 2024 | 880.60M |
| March 31, 2024 | 755.10M |
| December 31, 2023 | 747.60M |
| September 30, 2023 | 754.10M |
| June 30, 2023 | 663.40M |
| March 31, 2023 | 711.80M |
| December 31, 2022 | 656.20M |
| September 30, 2022 | 679.00M |
| June 30, 2022 | 651.50M |
| March 31, 2022 | 673.40M |
| December 31, 2021 | 477.40M |
| September 30, 2021 | 485.60M |
| June 30, 2021 | 558.40M |
| March 31, 2021 | 572.30M |
| December 31, 2020 | 694.70M |
| September 30, 2020 | 660.30M |
| June 30, 2020 | 597.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 563.80M |
| December 31, 2019 | -290.30M |
| September 30, 2019 | -301.50M |
| June 30, 2019 | -310.30M |
| March 31, 2019 | -296.60M |
| December 31, 2018 | 594.00M |
| September 30, 2018 | 413.80M |
| June 30, 2018 | 487.30M |
| March 31, 2018 | 410.80M |
| December 31, 2017 | 387.90M |
| September 30, 2017 | 650.20M |
| June 30, 2017 | 633.30M |
| March 31, 2017 | 698.80M |
| December 31, 2016 | 600.40M |
| September 30, 2016 | 445.68M |
| June 30, 2016 | 422.95M |
| March 31, 2016 | 344.80M |
| December 31, 2015 | 332.97M |
| September 30, 2015 | 427.31M |
| June 30, 2015 | 425.33M |
| March 31, 2015 | 320.87M |
| December 31, 2014 | 307.82M |
| September 30, 2014 | 310.50M |
| June 30, 2014 | 245.50M |
| March 31, 2014 | 391.82M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Liquidia Corp. | 150.69M |
| MannKind Corp. | -18.30M |
| Vertex Pharmaceuticals, Inc. | 3.796B |
| Savara, Inc. | -110.66M |
| Exelixis, Inc. | 1.172B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 310.20M |
| Cash from Investing (Quarterly) | 87.50M |
| Cash from Financing (Quarterly) | 125.80M |
| Free Cash Flow Per Share (Quarterly) | 4.415 |
| Free Cash Flow to Equity (Quarterly) | 202.20M |
| Free Cash Flow to Firm (Quarterly) | 204.79M |
| Free Cash Flow Yield | 4.48% |